Capital Growth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$35.1M |
| 2 |
Builders FirstSource
BLDR
|
+$31.2M |
| 3 |
FL
Foot Locker
FL
|
+$21.4M |
| 4 |
Lennar Class A
LEN
|
+$20.1M |
| 5 |
Devon Energy
DVN
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jones Lang LaSalle
JLL
|
+$40M |
| 2 |
SEM
Select Medical
SEM
|
+$36.7M |
| 3 |
Whirlpool
WHR
|
+$35.3M |
| 4 |
Avis
CAR
|
+$32.6M |
| 5 |
OneMain Financial
OMF
|
+$30.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 46.24% |
| 2 | Consumer Discretionary | 16.8% |
| 3 | Industrials | 10.96% |
| 4 | Energy | 9.22% |
| 5 | Financials | 7.6% |
Similar funds
Capital Growth Management's Q4 2021 Portfolio in Review
As of Q4 2021, Capital Growth Management held 86 positions worth $1.09B, down 0.1% from $1.09B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Capital Growth Management withdrew a net $130M in Q4 2021, closing 24 positions and reducing 17 holdings. Its most notable exit was Select Medical, an estimated $36.7M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 46% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Capital Growth Management opened a new position in Tenet Healthcare worth $39.2M.
- Capital Growth Management's largest Q4 2021 buy was Tenet Healthcare: 480,000 shares worth $39.2M.
- Capital Growth Management added most to CVS Health in Q4 2021, an estimated $8.78M increase.
- Capital Growth Management's biggest Q4 2021 reduction was Jones Lang LaSalle, cutting an estimated $40M.
- Capital Growth Management fully exited Select Medical in Q4 2021, selling an estimated $36.7M.
- Capital Growth Management's ten largest holdings make up 34% of its $1.09B portfolio in Q4 2021.
- Capital Growth Management opened 31 new positions and closed 24 in Q4 2021.
- Capital Growth Management's portfolio value fell 0.1% quarter-over-quarter to $1.09B.
Based on Capital Growth Management's 13F filing for Q4 2021, filed 11 Feb 2022.